Literature DB >> 24794265

Chemotherapy for oral and maxillofacial tumors: an update.

Ahmed Eid1, Shuang Li2, Rodolfo Garza3, Mark E Wong3.   

Abstract

Surgery is the primary intervention in oral and maxillofacial tumors and under ideal circumstances is curative. There is no evidence to support the use of induction or adjuvant chemotherapy in initial therapy of early stage tumors. Locally advanced tumors, non-resectable tumors as well as recurrence in early stage disease, need a multi-modality therapeutic approach involving chemotherapy. Palliative chemotherapy plays an important role in the treatment patients with metastatic oral and maxillofacial tumors. Chemotherapy and targeted agents plays an important role in the treatment of patients with rare oral and maxillofacial tumors such as sarcomas, lymphomas, and giant cell tumors.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Locally advanced; Maxillofacial tumors; Oral cavity tumors; Squamous cell carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24794265     DOI: 10.1016/j.coms.2014.01.004

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  3 in total

1.  MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion.

Authors:  Yadong Wu; Xiangjie Sun; Bin Song; Xiaoling Qiu; Jianjiang Zhao
Journal:  Cancer Med       Date:  2017-06-19       Impact factor: 4.452

2.  Low expression of miR-30a-5p induced the proliferation and invasion of oral cancer via promoting the expression of FAP.

Authors:  Peng Ruan; Zezhang Tao; Aili Tan
Journal:  Biosci Rep       Date:  2018-01-25       Impact factor: 3.840

3.  PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity.

Authors:  Xibo Pei; Zhou Zhu; Zhoujie Gan; Junyu Chen; Xin Zhang; Xinting Cheng; Qianbing Wan; Jian Wang
Journal:  Sci Rep       Date:  2020-02-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.